Hot flush and Application site hypersensitivity
Summary:
Application site hypersensitivity is found among people with Hot flush, especially for people who are female, 50-59 old.
The study analyzes which people have Application site hypersensitivity with Hot flush. It is created by eHealthMe based on reports of 32 people who have Hot flush from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Hot flush?
Hot flush (sudden feelings of heat) is found to be associated with 1,774 drugs and 2,342 conditions by eHealthMe. Check the latest studies of Hot flush.
What is Application site hypersensitivity?
Application site hypersensitivity is found to be associated with 107 drugs and 282 conditions by eHealthMe. Check the latest studies of Application site hypersensitivity.
32 people who have Hot Flush and Application Site Hypersensitivity are studied.

Gender of people who have Hot Flush and experienced Application Site Hypersensitivity *:
- female: 100 %
- male: 0.0 %
Age of people who have Hot Flush and experienced Application Site Hypersensitivity *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 10 %
- 50-59: 60 %
- 60+: 30 %
Common co-existing conditions for these people *:
- Night Sweats (sweating in night): 15 people, 46.88%
- Stress And Anxiety: 5 people, 15.62%
- Menopausal Symptoms: 3 people, 9.38%
- Vulvovaginal Dryness: 2 people, 6.25%
- Sleep Disorder: 2 people, 6.25%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 6.25%
- Mood Swings (an extreme or rapid change in mood): 2 people, 6.25%
- Insomnia (sleeplessness): 1 person, 3.12%
- Depression: 1 person, 3.12%
- Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 3.12%
Common drugs taken by these people *:
- Combipatch: 23 people, 71.88%
- Climara Pro: 4 people, 12.50%
- Minivelle: 3 people, 9.38%
- Wellbutrin: 2 people, 6.25%
- Zyrtec: 1 person, 3.12%
- Vivelle-Dot: 1 person, 3.12%
- Vitamins: 1 person, 3.12%
- Synthroid: 1 person, 3.12%
- Symbicort: 1 person, 3.12%
- Metformin: 1 person, 3.12%
Common symptoms for these people *:
- Application Site Erythema (redness of the skin at application site): 25 people, 78.12%
- Application Site Pruritus (application site severe itching of the skin): 22 people, 68.75%
- Application Site Irritation: 14 people, 43.75%
- Application Site Urticaria: 11 people, 34.38%
- Application Site Rash: 10 people, 31.25%
- Application Site Pain: 6 people, 18.75%
- Application Site Swelling: 6 people, 18.75%
- Application Site Vesicles (small bubble within a cell at application site): 5 people, 15.62%
- Application Site Dryness: 5 people, 15.62%
- Drug Ineffective: 3 people, 9.38%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Application site hypersensitivity?
- Check whether Application site hypersensitivity is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Hot flush (91,208 reports)
- Application site hypersensitivity (1,138 reports)
All the drugs that are associated with Application site hypersensitivity:
- Application site hypersensitivity (107 drugs)
All the conditions that are associated with Application site hypersensitivity:
- Application site hypersensitivity (282 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Application site hypersensitivity and Hot flush, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Chlorpheniramine Maleate and Ondansetron - a second ago
- Could Claritin cause Joint Crepitation? - 5 seconds ago
- Could Viibryd cause Drooling? - 9 seconds ago
- Gastroesophageal Reflux Disease and Hepatic Lesion - 10 seconds ago
- Could Tirosint cause Dizziness? - 11 seconds ago
- Drug interactions of Chlorpheniramine Maleate and Diphen - 13 seconds ago
- Could Effexor Xr cause Joint Range Of Motion Decreased? - 17 seconds ago
- 5 Htp vs. Venlafaxine Hydrochloride, side effect and effectiveness comparison - 20 seconds ago
- Drug interactions of Mannose and Diphenhydramine Hydrochloride - 21 seconds ago
- Maxzide vs. Aldactone, side effect and effectiveness comparison - 23 seconds ago